Four-Fold Increased Mortality from Sars-Cov-2 Infection in Patients with Hematologic Versus Non-Hematologic Malignancies Treated at the Largest Tertiary COVID-19 Center in Chicago/Rush University Medical Center (March 1, 2020-December 31,2020)

N.K.Y., P.C., & P.R.Y. contributed equally to this study Introduction: Many studies have concluded that active cancer patients infected with SARS-CoV-2 have a more complicated infection course and worse outcomes compared to the general patient population hospitalized with COVID-19. However, litt...

Descripción completa

Detalles Bibliográficos
Autores principales: Yun, Nicole K., Chebrolu, Praneeth, Yarnold, Paul R., Thomas, Joshua, Coggan, James L., Baranwal, Anmol, Bennett, Charles L., Varma, Ankur, Kuzel, Timothy M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society of Hematology. Published by Elsevier Inc. 2021
Materias:
904.Outcomes Research-Non-Malignant Conditions
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8701493/
http://dx.doi.org/10.1182/blood-2021-149694

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8701493/
http://dx.doi.org/10.1182/blood-2021-149694

Ejemplares similares